KMT2A and breast neoplasm: As a core subunit of MLL and SET1 histone H3K4 methyltransferase complexes, WDR5 is required for complex assembly and methyltransferase activity [2], which may be a newly identified coactivator whose expression is under long-range regulation during breast tumour progression.